Skip to content

Clinical trials

Observational Coronavirus Infections trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronavirus Infections Phase: Observational Country / region: China Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20191
20206
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status7
Completed2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Third Affiliated Hospital, Sun Yat-Sen University2
Maastricht University1
Nanfang Hospital, Southern Medical University1
National Institute of Allergy and Infectious Diseases (NIAID)1
Peking University Third Hospital1
Ruijin Hospital1
Second Affiliated Hospital, Zhejiang University, School of Medicine1
Shanghai 10th People's Hospital1
Shanghai Public Health Clinical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronavirus Infections10
COVID-191
Critical Illness1
Dyspnea1
Lung Neoplasms1
Post-Acute COVID-19 Syndrome1
Severe Acute Respiratory Syndrome1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.